|Age:||40 to 79 years old|
|Type:||Drug study, Phase 2|
1) Your participation will last approximately 8 to 9 months and will include 13 in person clinic visits. 2) Participants will be randomly assigned to receive daily oral doses of nilotinib or placebo - an inactive pill used in research studies to determine if the active study drug is effective. 3) Several blood samples will be collected throughout the study, along with required lumbar punctures at certain visits (2-3 total).
You may qualify for this study if you:
1) Are between 40 and 79 years of age 2) Have had PD for at least 5 years 3) You have been on a stable regimen of PD medications for at least 30 days prior to the screening visit 4) You are willing to undergo 2-3 lumbar punctures
Have any questions or want to learn more? Leave your contact details below and the research team will reach out to you.